97 related articles for article (PubMed ID: 17201188)
1. Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk.
Cattaneo F; Venesio T; Molatore S; Russo A; Fiocca R; Frattini M; Scovassi AI; Ottini L; Bertario L; Ranzani GN
Anticancer Res; 2006; 26(6B):4627-32. PubMed ID: 17201188
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
3. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
Medina-Franco H; Ramos-De la Medina A; Vizcaino G; Medina-Franco JL
Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
[TBL] [Abstract][Full Text] [Related]
5. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.
Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG
Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691
[TBL] [Abstract][Full Text] [Related]
6. The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies.
Wang GY; Lu CQ; Zhang RM; Hu XH; Luo ZW
Am J Epidemiol; 2008 Jan; 167(1):7-14. PubMed ID: 17971340
[TBL] [Abstract][Full Text] [Related]
7. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
8. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
9. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
[TBL] [Abstract][Full Text] [Related]
10. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.
Yamada H; Shinmura K; Ikeda S; Tao H; Otani T; Hanaoka T; Tsuneyoshi T; Tsugane S; Sugimura H
Scand J Gastroenterol; 2007 Dec; 42(12):1479-85. PubMed ID: 17852867
[TBL] [Abstract][Full Text] [Related]
11. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
Humar B; Graziano F; Cascinu S; Catalano V; Ruzzo AM; Magnani M; Toro T; Burchill T; Futschik ME; Merriman T; Guilford P
Oncogene; 2002 Nov; 21(53):8192-5. PubMed ID: 12444556
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
Kiemeney LA; van Houwelingen KP; Bogaerts M; Witjes JA; Swinkels DW; den Heijer M; Franke B; Schalken JA; Verhaegh GW
Eur J Cancer; 2006 Dec; 42(18):3219-27. PubMed ID: 16934975
[TBL] [Abstract][Full Text] [Related]
13. The E-cadherin -347G->GA promoter polymorphism and its effect on transcriptional regulation.
Shin Y; Kim IJ; Kang HC; Park JH; Park HR; Park HW; Park MA; Lee JS; Yoon KA; Ku JL; Park JG
Carcinogenesis; 2004 Jun; 25(6):895-9. PubMed ID: 14729585
[TBL] [Abstract][Full Text] [Related]
14. CDH1 C-160A promoter polymorphism and gastric cancer risk.
Corso G; Berardi A; Marrelli D; Pedrazzani C; Garosi L; Pinto E; Roviello F
Eur J Cancer Prev; 2009 Feb; 18(1):46-9. PubMed ID: 19077564
[TBL] [Abstract][Full Text] [Related]
15. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities.
Li LC; Chui RM; Sasaki M; Nakajima K; Perinchery G; Au HC; Nojima D; Carroll P; Dahiya R
Cancer Res; 2000 Feb; 60(4):873-6. PubMed ID: 10706097
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease.
Muise AM; Walters TD; Glowacka WK; Griffiths AM; Ngan BY; Lan H; Xu W; Silverberg MS; Rotin D
Gut; 2009 Aug; 58(8):1121-7. PubMed ID: 19398441
[TBL] [Abstract][Full Text] [Related]
17. Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer.
Tsukino H; Kuroda Y; Imai H; Nakao H; Qiu D; Komiya Y; Inatomi H; Hamasaki T; Kohshi K; Osada Y; Katoh T
Urol Int; 2004; 72(3):203-7. PubMed ID: 15084762
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer.
Lin J; Dinney CP; Grossman HB; Jhamb M; Zhu Y; Spitz MR; Wu X
Clin Genet; 2006 Sep; 70(3):240-5. PubMed ID: 16922727
[TBL] [Abstract][Full Text] [Related]
19. The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease.
Rife T; Rasoul B; Pullen N; Mitchell D; Grathwol K; Kurth J
J Neurosci Res; 2009 Aug; 87(10):2319-25. PubMed ID: 19326438
[TBL] [Abstract][Full Text] [Related]
20. Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke.
Kim NS; Oh SM; Ko MM; Cha MH; Kang BK; Bang OS
Clin Biochem; 2009 Nov; 42(16-17):1699-704. PubMed ID: 19619519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
